News & Updates
Filter by Specialty:
Survival advantage in COVID-19 seen with 8-mg/kg tocilizumab
In the treatment of hospitalized patients with COVID-19, survival outcomes appear to be more favourable with the 8-mg/kg tocilizumab regimen than with the fixed-dose tocilizumab regimen or sarilumab, according to a study.
Survival advantage in COVID-19 seen with 8-mg/kg tocilizumab
09 Feb 2023
Psychiatric comorbidity boosts healthcare use in youth with newly diagnosed SLE
Young patients with newly diagnosed systemic lupus erythematosus (SLE) are vulnerable to psychiatric comorbidity, which tends to increase healthcare utilization, according to a study.
Psychiatric comorbidity boosts healthcare use in youth with newly diagnosed SLE
09 Feb 2023
Biologic agents raise IBD risk among axSpA patients
Based on observational studies, patients with axial spondyloarthritis (axSpA) treated with biologics are at higher risk of inflammatory bowel disease (IBD), while findings from randomized controlled trials (RCTs) suggest that treatment with etanercept (ETN) tends to increase such risk compared to other antitumour necrosis factor (anti-TNF) therapies, according to the result of a meta-analysis.
